Mao FF - Search Results

1

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism.

Mao FF, Gao SS, Huang YJ, Zhou N, Feng JK, Liu ZH, Zhang YQ, Yuan LY, Wei G, Cheng SQ. Mao FF, et al. Front Nutr. 2023 Feb 14;10:1076569. doi: 10.3389/fnut.2023.1076569. eCollection 2023. Front Nutr. 2023. PMID: 36866057 Free PMC article.

2

Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.

Cheng YQ, Wang K, Zhang XP, Wei XB, Jiang YB, Hu YR, Mao FF, Guo WX, Shi J, Cheng SQ. Cheng YQ, et al. Among authors: mao ff. J Gastroenterol Hepatol. 2019 Jul;34(7):1214-1221. doi: 10.1111/jgh.14537. Epub 2018 Nov 28. J Gastroenterol Hepatol. 2019. PMID: 30402968

3

The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.

Feng X, Lu T, Li J, Yang R, Hu L, Ye Y, Mao F, He L, Xu J, Wang Z, Liu Y, Zhang Y, Ji H, Zhao Y, Cheng S, Tian W, Zhang L. Feng X, et al. Hepatology. 2020 Jun;71(6):1988-2004. doi: 10.1002/hep.30961. Epub 2020 Feb 16. Hepatology. 2020. PMID: 31538665

4

Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.

Yang Y, Mao F, Guo L, Shi J, Wu M, Cheng S, Guo W. Yang Y, et al. Dig Liver Dis. 2021 Apr;53(4):474-485. doi: 10.1016/j.dld.2021.01.003. Epub 2021 Feb 6. Dig Liver Dis. 2021. PMID: 33563583

5

Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis.

Liu ZH, Sun JX, Feng JK, Yang SY, Chen ZH, Liu C, Chai ZT, Mao FF, Guo WX, Shi J, Cheng SQ. Liu ZH, et al. Among authors: mao ff. Front Oncol. 2022 Mar 15;12:835559. doi: 10.3389/fonc.2022.835559. eCollection 2022. Front Oncol. 2022. PMID: 35372001 Free PMC article.

6

Mechanistic Insights into the Mechanism of Inhibitor Selectivity toward the Dark Kinase STK17B against Its High Homology STK17A.

Liu C, Zhang Y, Zhang Y, Liu Z, Mao F, Chai Z. Liu C, et al. Molecules. 2022 Jul 21;27(14):4655. doi: 10.3390/molecules27144655. Molecules. 2022. PMID: 35889528 Free PMC article.

7

A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study.

Sun J, Liu C, Shi J, Wang N, Jiang D, Mao F, Gu J, Zhou L, Shen L, Lau WY, Cheng S. Sun J, et al. Chin Med J (Engl). 2022 Oct 5;135(19):2338-2343. doi: 10.1097/CM9.0000000000001952. Chin Med J (Engl). 2022. PMID: 36103975 Free PMC article.

8

Zhu H, Mao F, Wang K, Feng J, Cheng S. Zhu H, et al. Front Genet. 2022 Sep 23;13:972212. doi: 10.3389/fgene.2022.972212. eCollection 2022. Front Genet. 2022. PMID: 36212138 Free PMC article.

9

Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.

Yuan L, Feng J, Zhang Y, Lu C, Xu L, Liang C, Liu Z, Mao F, Xiang Y, Wang W, Wang K, Cheng S. Yuan L, et al. Eur J Surg Oncol. 2023 Jul;49(7):1226-1233. doi: 10.1016/j.ejso.2023.01.020. Epub 2023 Jan 18. Eur J Surg Oncol. 2023. PMID: 36739252

10

Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study.

Zhang YQ, Wang K, Feng JK, Yuan LY, Liang C, Xiang YJ, Wang X, Mao FF, Cheng SQ. Zhang YQ, et al. Among authors: mao ff. Front Oncol. 2023 May 1;13:1101038. doi: 10.3389/fonc.2023.1101038. eCollection 2023. Front Oncol. 2023. PMID: 37197414 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters